👀 Ones to watch: The MOST undervalued stocks to buy right nowSee Undervalued Stocks

Blackrock capital allocation term trust sees $84,182 stock sale by Saba Capital

Published 26/11/2024, 01:26
Blackrock capital allocation term trust sees $84,182 stock sale by Saba Capital
BCAT
-

In a recent transaction, Saba Capital Management, L.P., a significant stakeholder in BlackRock (NYSE:BLK) Capital Allocation Term Trust (NYSE:BCAT), sold 5,219 shares of common stock. The shares were sold at an average price of $16.13 each, amounting to a total transaction value of $84,182. Following this sale, Saba Capital Management retains ownership of 14,256,099 shares in the trust. This transaction was disclosed in a filing with the Securities and Exchange Commission, showcasing Saba Capital's ongoing adjustments to its investment portfolio in the trust.

InvestingPro Insights

To provide additional context to Saba Capital Management's recent transaction involving BlackRock Capital Allocation Term Trust (NYSE:BCAT), it's worth examining some key financial metrics and insights from InvestingPro.

BCAT currently boasts a substantial dividend yield of 21.39%, with the most recent ex-dividend date on November 15, 2024. This aligns with one of the InvestingPro Tips, which notes that BCAT "pays a significant dividend to shareholders." This high yield could be a factor in Saba Capital's decision to maintain a large position in the trust despite the recent sale.

The trust's market capitalization stands at $1.73 billion, with a relatively low P/E ratio of 8.78. This valuation metric might suggest that the stock is potentially undervalued, which could explain why Saba Capital still holds a significant stake even after selling a portion of its shares.

Another InvestingPro Tip indicates that BCAT "generally trades with low price volatility." This characteristic may be attractive to institutional investors like Saba Capital, who often seek stable investments for their portfolios. The trust's year-to-date price total return of 25.31% and one-year price total return of 28.79% demonstrate solid performance, which could have influenced Saba Capital's decision-making process regarding their holdings.

It's worth noting that InvestingPro offers additional tips and insights beyond what's mentioned here. Investors interested in a more comprehensive analysis of BCAT may find value in exploring the full range of InvestingPro Tips available.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2024 - Fusion Media Limited. All Rights Reserved.